Estrella Immunopharma, Inc. (ESLA) earnings date, market-implied expected move, and options open interest by expiry

earnings room

0.51−3.61%

Next report

fiscal Q3 2026

Sep 24

timing tbd · estimated date

days out

Intraday

−8.01% since 10 AM

High 0.55 at 10:15 am ET, low 0.51 at 2:00 pm ET.

Revenue flow

not on file

No filed income statement on record yet. These are the standardized lines of a company’s own filing, so a company that has not reported one has nothing to show here.

Expected move

No options chain priced for this ticker yet.

Linked exposure

placeholder

No linked names measured for this ticker yet.

Positioning

placeholder

No options positioning captured for this ticker yet.

Earnings history

implied in pale · realized in full ink

The record starts accreting with the next priced report.

3-quarter memory

Event sensitivity

release-day history · not a forecast

FOMCrate decision0.9×up 13 of 24±4.5% vs ±5.2% · 24
NFPjobs report0.8×up 1 of 9±4.4% vs ±5.2% · 9
CPIconsumer prices0.8×up 3 of 9±4.3% vs ±5.2% · 9
PCEpersonal income & outlays0.8×up 7 of 18±4.2% vs ±5.2% · 18
GDPgross domestic product0.8×up 6 of 18±4.1% vs ±5.2% · 18
PPIproducer prices0.7×up 4 of 9±3.4% vs ±5.2% · 9
CPROFcorporate profits0.5×up 4 of 11±2.6% vs ±5.2% · 11

Past release days against ESLA’s ordinary ±5.2% day, from our own stored closes. History, not a forecast; kinds with fewer than six releases are omitted.

Track ESLA

Watchlist prices, news filtered to it, and its next report on your desk.

Market-implied ranges describe what current option prices imply, never a forecast. Prices via Intrinio.